1evs: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1evs.jpg|left|200px]]
{{Seed}}
[[Image:1evs.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1evs|  PDB=1evs  |  SCENE=  }}  
{{STRUCTURE_1evs|  PDB=1evs  |  SCENE=  }}  


'''CRYSTAL STRUCTURE OF HUMAN ONCOSTATIN M'''
===CRYSTAL STRUCTURE OF HUMAN ONCOSTATIN M===




==Overview==
<!--
BACKGROUND: The cytokine oncostatin M (OSM) inhibits growth of certain tumour-derived cells, induces proliferation in other cell types (e.g. haemangioblasts) and is a mediator of inflammatory responses. Its mechanism of action is via specific binding to gp130 and either the leukaemia inhibitory factor receptor (LIFR) or oncostatin M receptor (OSMR) systems at the cell surface to form an active signalling complex. RESULTS: We report here the crystal structure of human oncostatin M (hOSM) along with mutagenesis data which map the receptor-binding epitopes of the molecule. The structure was determined to a resolution of 2.2 A and conforms to the haematopoietin cytokine up-up-down-down four-helix bundle topology. The site 2 epitope, responsible for gp130 binding, is centred around Gly120 which forms a 'dimple' on the surface of the molecule located on helices A and C. The site 3 motif, responsible for LIFR and OSMR binding, consists of a protruding Phe160/Lys163 pair located at the start of helix D. CONCLUSIONS: The data presented allow functional dissection of the receptor-binding interfaces to atomic resolution. Modelling suggests that the gp130 residue Phe169 packs into the site 2 dimple in an analogous fashion to structurally equivalent residues at the growth hormone-growth hormone receptor interface, implying that certain key features may underlie recognition across the whole cytokine/receptor superfamily. Conversely, detailed comparison of the available structures suggests that variations on a common theme dictate the specificity of receptor-ligand interactions within the gp130 family of cytokines.
The line below this paragraph, {{ABSTRACT_PUBMED_10997905}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 10997905 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_10997905}}


==About this Structure==
==About this Structure==
Line 30: Line 34:
[[Category: 4-helix bundle]]
[[Category: 4-helix bundle]]
[[Category: Gp130 binding cytokine]]
[[Category: Gp130 binding cytokine]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 15:34:37 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 02:05:47 2008''